Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, VK Prajapati Vaccine 36 (17), 2262-2272, 2018 | 108 | 2018 |
Designing B‐and T‐cell multi‐epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection R Kumar Pandey, R Ojha, A Mishra, V Kumar Prajapati Journal of cellular biochemistry 119 (9), 7631-7642, 2018 | 92 | 2018 |
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment B Naik, N Gupta, R Ojha, S Singh, VK Prajapati, D Prusty International Journal of Biological Macromolecules 160, 1-17, 2020 | 91 | 2020 |
Emerging role of circular RNAs as potential biomarkers for the diagnosis of human diseases R Ojha, R Nandani, N Chatterjee, VK Prajapati Circular RNAs: Biogenesis and Functions, 141-157, 2018 | 76 | 2018 |
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product … BK Kumar, n Faheem, KVGC Sekhar, R Ojha, VK Prajapati, A Pai, ... Journal of Biomolecular Structure and Dynamics 40 (3), 1363-1386, 2022 | 73 | 2022 |
Strategic development of a next-generation multi-epitope vaccine to prevent Nipah virus zoonotic infection R Ojha, A Pareek, RK Pandey, D Prusty, VK Prajapati ACS omega 4 (8), 13069-13079, 2019 | 65 | 2019 |
Emerging role of circulating microRNA in the diagnosis of human infectious diseases R Ojha, R Nandani, RK Pandey, A Mishra, VK Prajapati Journal of cellular physiology 234 (2), 1030-1043, 2019 | 59 | 2019 |
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19 R Ojha, N Gupta, B Naik, S Singh, VK Verma, D Prusty, VK Prajapati European Journal of Pharmaceutical Sciences 151, 105375, 2020 | 55 | 2020 |
Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic … N Chatterjee, R Ojha, N Khatoon, VK Prajapati International journal of biological macromolecules 118, 180-188, 2018 | 35 | 2018 |
Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection RK Pandey, M Ali, R Ojha, TK Bhatt, VK Prajapati Vaccine 36 (30), 4555-4565, 2018 | 29 | 2018 |
Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and leishmania antigens R Ojha, RK Pandey, VK Prajapati International journal of biological macromolecules 156, 548-557, 2020 | 28 | 2020 |
Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins N Khatoon, RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, ... Journal of Biomolecular Structure and Dynamics 37 (9), 2381-2393, 2019 | 25 | 2019 |
Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications B Naik, VSK Mattaparthi, N Gupta, R Ojha, P Das, S Singh, VK Prajapati, ... Journal of Biomolecular Structure and Dynamics 40 (19), 9543-9567, 2022 | 24 | 2022 |
Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism N Khatoon, R Ojha, A Mishra, VK Prajapati Vaccine 36 (42), 6290-6300, 2018 | 23 | 2018 |
Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicity R Ojha, VK Prajapati Journal of Cellular Physiology 236 (12), 8020-8034, 2021 | 16 | 2021 |
Conglomeration of novel Culex quinquefasciatus salivary proteins to contrive multi-epitope subunit vaccine against infections caused by blood imbibing transmitter R Ojha, N Khatoon, VK Prajapati International journal of biological macromolecules 118, 834-843, 2018 | 16 | 2018 |
Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein–Barr virus‐associated malignancy R Ojha, R Nandani, VK Prajapati Journal of Cellular Physiology 234 (5), 6437-6448, 2019 | 13 | 2019 |
Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2 R Ojha, K Gurjar, TS Ratnakar, A Mishra, VK Prajapati Human Immunology 83 (4), 346-355, 2022 | 11 | 2022 |
Immunoselective algorithm to devise multi-epitope subunit vaccine fighting against human cytomegalovirus infection RK Pandey, R Ojha, K Dipti, R Kumar, VK Prajapati Infection, Genetics and Evolution 82, 104282, 2020 | 9 | 2020 |
Combinatorial screening algorithm to engineer multiepitope subunit vaccine targeting human T‐lymphotropic virus‐1 infection RK Pandey, R Ojha, N Chatterjee, N Upadhyay, A Mishra, VK Prajapati Journal of Cellular Physiology 234 (6), 8717-8726, 2019 | 9 | 2019 |